Exact Sciences Corporation reported impairment charges for the third quarter ended September 30, 2022. For the quarter, the company reported impairment of long-lived assets of $5,946,000 against $20,210,000 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
63.24 USD | -0.46% | +0.03% | -14.52% |
Apr. 17 | Exact Sciences Corporation announced that it has received $266.75 million in funding | CI |
Apr. 15 | Sector Update: Health Care Stocks Advance Premarket Monday | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.52% | 11.53B | |
+44.03% | 3.31B | |
-33.09% | 2.11B | |
-18.60% | 2.05B | |
-27.59% | 1.49B | |
+17.10% | 1.02B | |
-3.06% | 741M | |
-33.50% | 426M | |
-46.94% | 374M | |
+27.44% | 372M |
- Stock Market
- Equities
- EXAS Stock
- News Exact Sciences Corporation
- Exact Sciences Corporation Reports Impairment Charges for the Third Quarter Ended September 30, 2022